Difference between revisions of "MT-LIPCAR"
Chunlei Yu (talk | contribs) (Created page with "==Annotated Information== ===Approved Symbol=== MT-LIPCAR ===Approved Name=== mitochondrially encoded long non-coding cardiac associated RNA ===Previous Symbols=== ===Synonym...") |
|||
| Line 16: | Line 16: | ||
===pubmed IDs=== | ===pubmed IDs=== | ||
24663402 | 24663402 | ||
| + | |||
| + | ===Characteristics=== | ||
| + | LIPCAR, a long intergenic noncoding RNA predicting cardiac remodeling and survival of patients with HF.<ref name="ref1" />. | ||
| + | |||
| + | ===Cellular Localization=== | ||
| + | A mitochondrial long noncoding RNA.<ref name="ref1" />. | ||
| + | |||
| + | ===Function=== | ||
| + | LIPCAR is a novel biomarker of cardiac remodeling and predicts future death in patients with heart failure. | ||
| + | |||
| + | ===Regulation=== | ||
| + | The mitochondrial long noncoding RNA uc022bqs.1 (LIPCAR) was downregulated early after myocardial infarction but upregulated during later stages.<ref name="ref1" />. | ||
| + | |||
| + | ===Diseases=== | ||
| + | * heart failure | ||
| + | |||
| + | ===Expression=== | ||
| + | LIPCAR are downregulated at baseline, but significantly upregulated later on during the development of HF. | ||
| + | |||
| + | ==Labs working on this lncRNA== | ||
| + | * From the Institute of Molecular and Translational Therapeutic Strategies (IMTTS), IFB-Tx (R.K., I.V., J.F., A.H., T.T.) and REBIRTH Excellence Cluster (T.T.), Hannover Medical School, Hannover, Germany; Inserm, U744, University Lille Nord de France, Lille, France (C.B., F.M., G.L., P.d.G., F.P.); Institut Pasteur de Lille, Lille, France (C.B., F.M., G.L., P.d.G., F.P.); Centre Hospitalier Régional et Universitaire de Lille, Lille, France (C.B., G.L., P.d.G., F.P.); Faculté de Médecine de Lille, Lille, France (C.B., G.L.); and National Heart and Lung Institute, Imperial College London, London, United Kingdom (T.T.). <ref name="ref1" />. | ||
| + | |||
| + | ==References== | ||
| + | <references> | ||
| + | <ref name="ref1"> Kumarswamy R, Bauters C, Volkmann I, Maury F, Fetisch J, Holzmann A, Lemesle G, de Groote P, Pinet F, Thum T.(2014) Circulating Long Noncoding RNA, LIPCAR, Predicts Survival in Patients With Heart Failure.</ref>(1) | ||
| + | </references> | ||
Revision as of 11:08, 29 June 2016
Annotated Information
Approved Symbol
MT-LIPCAR
Approved Name
mitochondrially encoded long non-coding cardiac associated RNA
Previous Symbols
Synonyms
uc022bqs.1, LIPCAR
Chromosome
mitochondria
OMIM ID
_
Ensembl ID
_
pubmed IDs
24663402
Characteristics
LIPCAR, a long intergenic noncoding RNA predicting cardiac remodeling and survival of patients with HF.[1].
Cellular Localization
A mitochondrial long noncoding RNA.[1].
Function
LIPCAR is a novel biomarker of cardiac remodeling and predicts future death in patients with heart failure.
Regulation
The mitochondrial long noncoding RNA uc022bqs.1 (LIPCAR) was downregulated early after myocardial infarction but upregulated during later stages.[1].
Diseases
- heart failure
Expression
LIPCAR are downregulated at baseline, but significantly upregulated later on during the development of HF.
Labs working on this lncRNA
- From the Institute of Molecular and Translational Therapeutic Strategies (IMTTS), IFB-Tx (R.K., I.V., J.F., A.H., T.T.) and REBIRTH Excellence Cluster (T.T.), Hannover Medical School, Hannover, Germany; Inserm, U744, University Lille Nord de France, Lille, France (C.B., F.M., G.L., P.d.G., F.P.); Institut Pasteur de Lille, Lille, France (C.B., F.M., G.L., P.d.G., F.P.); Centre Hospitalier Régional et Universitaire de Lille, Lille, France (C.B., G.L., P.d.G., F.P.); Faculté de Médecine de Lille, Lille, France (C.B., G.L.); and National Heart and Lung Institute, Imperial College London, London, United Kingdom (T.T.). [1].
